A prospective trial investigating the role of Serum 25-Hydroxyvitamin D in diagnosis and prognosis of bladder cancer (original) (raw)
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort
Trude Robsahm
Clinical Epidemiology
View PDFchevron_right
Low Plasma 25-Hydoxyvitamin D at Diagnosis Predicts Poor Outcomes in Patients with Bladder Cancer: A Prospective Cohort Study
Amani KALLEL
Nutrition and Cancer
View PDFchevron_right
Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study
Y. Allory, M. Mendez-Pertuz
JNCI Journal of the National Cancer Institute, 2012
View PDFchevron_right
Serum Vitamin D and Risk of Bladder Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Alison Mondul
Cancer Epidemiology, Biomarkers & Prevention, 2012
View PDFchevron_right
Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients
Anna Brożyna
International Journal of Molecular Sciences, 2015
View PDFchevron_right
Serum Vitamin D and Risk of Bladder Cancer
Alison Mondul
Cancer Research, 2010
View PDFchevron_right
Circulating 25-hydroxyvitamin D (25-OHD) levels and prognosis among cancer patients: a systematic review
Graham Colditz
Cancer Epidemiology Biomarkers & Prevention, 2014
View PDFchevron_right
Relationship of Vitamin D Monitoring and Status to Bladder Cancer Survival in Veterans
Beth Bailey
Southern Medical Journal, 2013
View PDFchevron_right
The Association between Pre-Treatment Serum 25-Hydroxyvitamin D and Survival in Newly Diagnosed Stage IV Prostate Cancer
Subhasis Misra
PLOS ONE, 2015
View PDFchevron_right
Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis
Trude Robsahm
Clinical Epidemiology, 2019
View PDFchevron_right
Circulating 25-Hydroxyvitamin D 3 and Survival after Diagnosis with Kidney Cancer
Per Magne Ueland
View PDFchevron_right
Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade (Gilbert)
Becky Gilbert
2012
View PDFchevron_right
Circulating 25-hydroxyvitamin D Levels and Prognosis among Cancer Patients: A Systematic Review
nhi nguyen
Cancer Epidemiology, Biomarkers & Prevention, 2014
View PDFchevron_right
Serum 25-Hydroxy Vitamin D Levels in Bulgarian Patients with Prostate Cancer: a Pilot Study
Alexander Hinev
Clinical laboratory
View PDFchevron_right
Low Plasmatic 25-hydroxyvitamin D at Diagnosis is Associated with Axillary Invasion, Chemoresistance and Metastasis in Women with Breast Cancer
Ana Cristina Herrera
Archives of Medical Research, 2020
View PDFchevron_right
Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort
Oivind Midttun
American journal of epidemiology, 2014
View PDFchevron_right
Serum 25-hydroxyvitamin D levels in early and advanced breast cancer
Samia Girgis
Journal of Clinical Pathology, 2006
View PDFchevron_right
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma
sara gandini
International Journal of Cancer, 2011
View PDFchevron_right
Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study
Trude Robsahm
BMJ open, 2018
View PDFchevron_right
Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)
Bruce Hollis
Clinical Cancer Research, 2019
View PDFchevron_right
Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study
Steinar Tretli, Gary Schwartz, Trude Robsahm
Cancer Causes & Control, 2012
View PDFchevron_right
Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival
Wichai Purisa
Asian Pacific Journal of Cancer Prevention, 2019
View PDFchevron_right
The role of serum 25-hydroxyvitamin D, ionized calcium and phosphorus in breast cancer females: A case-control study
Taha Hewala
International Journal of Basic and Applied Sciences, 2015
View PDFchevron_right
Circulating 25-Hydroxyvitamin D and Risk of Kidney Cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
Xiao-Ou Shu
American Journal of Epidemiology, 2010
View PDFchevron_right
A survey on the relationship between serum 25-hydroxy vitamin D level and tumor characteristics in patients with breast cancer
Mohsen Aarabi
International Journal of Hematology-Oncology and Stem Cell Research, 2016
View PDFchevron_right
Prognostic impact of serum 25-hydroxivitamin D [25(OH)D] concentrations in patients with lymphoid malignancies
Salah Aref
Hematology, 2013
View PDFchevron_right
Vitamin D and prostate cancer: a prediagnostic study with stored sera
Elizabeth Corder
PubMed, 1993
View PDFchevron_right
Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
Arti Varanasi
American Journal of Epidemiology, 2010
View PDFchevron_right
Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer
Roya Dolatkhah
Asian Pacific journal of cancer prevention : APJCP, 2011
View PDFchevron_right
Prognostic Impact of 25-Hydroxyvitamin D Levels in Egyptian Patients with Breast Cancer
Shereen Elshorbagy
Journal of Cancer Science & Therapy, 2017
View PDFchevron_right
Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study
Edward Gorham
PLOS ONE, 2016
View PDFchevron_right
The clinical relevance of urine-based markers for diagnosis of bladder cancer
Mahmoud Balbaa
Medical Oncology, 2011
View PDFchevron_right